| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms, Germ Cell and Embryonal | 5 | 2023 | 492 | 1.560 |
Why?
|
| Mesenchymal Stem Cells | 23 | 2011 | 1645 | 1.410 |
Why?
|
| Myocardial Reperfusion Injury | 15 | 2011 | 480 | 1.210 |
Why?
|
| Splenectomy | 3 | 2018 | 391 | 1.160 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 14 | 2011 | 501 | 1.110 |
Why?
|
| Wilms Tumor | 3 | 2023 | 376 | 0.980 |
Why?
|
| Catheterization, Central Venous | 3 | 2021 | 526 | 0.860 |
Why?
|
| Endotoxemia | 4 | 2011 | 196 | 0.820 |
Why?
|
| Hepatocyte Growth Factor | 7 | 2015 | 270 | 0.780 |
Why?
|
| Renal Insufficiency | 3 | 2023 | 808 | 0.670 |
Why?
|
| Transforming Growth Factor alpha | 8 | 2011 | 135 | 0.650 |
Why?
|
| Gallbladder Diseases | 1 | 2020 | 139 | 0.640 |
Why?
|
| Intestinal Obstruction | 1 | 2023 | 432 | 0.640 |
Why?
|
| Cholecystectomy | 2 | 2020 | 404 | 0.610 |
Why?
|
| Splenic Diseases | 1 | 2018 | 91 | 0.580 |
Why?
|
| Sepsis | 5 | 2018 | 2585 | 0.540 |
Why?
|
| Appendix | 1 | 2017 | 109 | 0.520 |
Why?
|
| Myocardium | 15 | 2011 | 4746 | 0.490 |
Why?
|
| Hepatoblastoma | 1 | 2015 | 90 | 0.470 |
Why?
|
| Neoplasms | 10 | 2023 | 22142 | 0.460 |
Why?
|
| Vascular Endothelial Growth Factor A | 16 | 2011 | 3493 | 0.450 |
Why?
|
| Ovarian Neoplasms | 4 | 2023 | 4872 | 0.450 |
Why?
|
| Neuroblastoma | 4 | 2024 | 1246 | 0.440 |
Why?
|
| Child | 42 | 2024 | 80154 | 0.430 |
Why?
|
| Paracrine Communication | 5 | 2011 | 276 | 0.420 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.420 |
Why?
|
| Myocardial Ischemia | 11 | 2011 | 2133 | 0.410 |
Why?
|
| Spleen | 2 | 2018 | 2290 | 0.410 |
Why?
|
| Hernia, Inguinal | 3 | 2021 | 220 | 0.390 |
Why?
|
| Kidney Neoplasms | 3 | 2023 | 4251 | 0.380 |
Why?
|
| Gastroschisis | 1 | 2012 | 99 | 0.360 |
Why?
|
| STAT3 Transcription Factor | 6 | 2011 | 872 | 0.340 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2010 | 106 | 0.330 |
Why?
|
| Child, Preschool | 21 | 2024 | 42225 | 0.330 |
Why?
|
| Teratoma | 2 | 2023 | 404 | 0.330 |
Why?
|
| Infant | 21 | 2024 | 36170 | 0.320 |
Why?
|
| Cardiac Tamponade | 1 | 2010 | 175 | 0.320 |
Why?
|
| Peritoneal Dialysis | 1 | 2010 | 159 | 0.320 |
Why?
|
| Duodenal Obstruction | 1 | 2008 | 23 | 0.310 |
Why?
|
| Osteosarcoma | 2 | 2024 | 896 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2011 | 8164 | 0.300 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 247 | 0.300 |
Why?
|
| Duodenal Diseases | 1 | 2008 | 99 | 0.300 |
Why?
|
| Bone Neoplasms | 3 | 2024 | 2527 | 0.290 |
Why?
|
| Culture Media | 1 | 2009 | 894 | 0.280 |
Why?
|
| Adolescent | 29 | 2024 | 88300 | 0.280 |
Why?
|
| Interleukin-1beta | 6 | 2011 | 1002 | 0.270 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 2217 | 0.270 |
Why?
|
| Immunomodulation | 1 | 2010 | 548 | 0.270 |
Why?
|
| Heart | 6 | 2010 | 4431 | 0.260 |
Why?
|
| Interleukin-6 | 8 | 2011 | 3210 | 0.260 |
Why?
|
| Neoplasms, Second Primary | 3 | 2024 | 1052 | 0.250 |
Why?
|
| Cell Proliferation | 5 | 2010 | 10423 | 0.240 |
Why?
|
| Catheters, Indwelling | 2 | 2021 | 426 | 0.240 |
Why?
|
| Rats | 24 | 2011 | 23705 | 0.230 |
Why?
|
| Infant, Newborn | 11 | 2023 | 26200 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2011 | 4340 | 0.230 |
Why?
|
| Hematoma | 1 | 2008 | 763 | 0.220 |
Why?
|
| Male | 62 | 2024 | 360703 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 5 | 2010 | 255 | 0.220 |
Why?
|
| Incidence | 10 | 2024 | 21366 | 0.210 |
Why?
|
| Retrospective Studies | 23 | 2024 | 80675 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 1249 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2293 | 0.210 |
Why?
|
| Interleukin-10 | 4 | 2011 | 1176 | 0.200 |
Why?
|
| Humans | 73 | 2024 | 761222 | 0.200 |
Why?
|
| Survivors | 5 | 2023 | 2369 | 0.200 |
Why?
|
| Cell Survival | 4 | 2010 | 5778 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1651 | 0.190 |
Why?
|
| Hernia, Femoral | 1 | 2021 | 18 | 0.190 |
Why?
|
| Indenes | 1 | 2021 | 59 | 0.180 |
Why?
|
| Female | 49 | 2024 | 392552 | 0.180 |
Why?
|
| Polycythemia | 1 | 2021 | 124 | 0.180 |
Why?
|
| Postoperative Complications | 3 | 2021 | 15637 | 0.170 |
Why?
|
| Appendectomy | 2 | 2020 | 434 | 0.170 |
Why?
|
| Paraganglioma | 1 | 2021 | 143 | 0.170 |
Why?
|
| Estrogen Receptor beta | 3 | 2009 | 169 | 0.170 |
Why?
|
| Hernia, Umbilical | 1 | 2021 | 102 | 0.170 |
Why?
|
| Stem Cells | 2 | 2009 | 3517 | 0.170 |
Why?
|
| Tacrolimus | 1 | 2023 | 736 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4310 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2010 | 585 | 0.160 |
Why?
|
| Estrogens | 4 | 2010 | 1522 | 0.160 |
Why?
|
| Receptor Cross-Talk | 2 | 2009 | 115 | 0.160 |
Why?
|
| Risk Factors | 10 | 2024 | 74241 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2011 | 2864 | 0.160 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2011 | 680 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 3031 | 0.150 |
Why?
|
| Stem Cell Transplantation | 4 | 2010 | 1600 | 0.150 |
Why?
|
| Rectal Diseases | 1 | 2019 | 142 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2010 | 3422 | 0.150 |
Why?
|
| Cyclosporine | 1 | 2000 | 776 | 0.150 |
Why?
|
| Testicular Diseases | 1 | 2018 | 73 | 0.150 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 1923 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 344 | 0.140 |
Why?
|
| Glucose | 1 | 2009 | 4342 | 0.140 |
Why?
|
| Hernia, Ventral | 1 | 2021 | 218 | 0.140 |
Why?
|
| Cell Hypoxia | 2 | 2009 | 656 | 0.140 |
Why?
|
| Signal Transduction | 10 | 2021 | 23419 | 0.140 |
Why?
|
| North America | 1 | 2020 | 1284 | 0.130 |
Why?
|
| Thymectomy | 1 | 2017 | 195 | 0.130 |
Why?
|
| Animals | 39 | 2011 | 168089 | 0.130 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 732 | 0.130 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2017 | 165 | 0.130 |
Why?
|
| Neoplasm Staging | 4 | 2023 | 11119 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1132 | 0.130 |
Why?
|
| Graft Survival | 2 | 2010 | 3843 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 589 | 0.120 |
Why?
|
| Lipopolysaccharides | 4 | 2011 | 2199 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 2 | 2009 | 582 | 0.120 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1995 | 41 | 0.120 |
Why?
|
| Cells, Cultured | 8 | 2011 | 18927 | 0.120 |
Why?
|
| Survival Rate | 5 | 2024 | 12728 | 0.120 |
Why?
|
| Hepatitis Antibodies | 1 | 1995 | 67 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 3803 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 1273 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2023 | 9319 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 2 | 2019 | 1923 | 0.120 |
Why?
|
| Hospital Charges | 1 | 2016 | 350 | 0.120 |
Why?
|
| Myasthenia Gravis | 1 | 2017 | 214 | 0.120 |
Why?
|
| Graft vs Host Reaction | 1 | 1994 | 99 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2011 | 193 | 0.110 |
Why?
|
| Enteral Nutrition | 2 | 2017 | 794 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 1158 | 0.110 |
Why?
|
| Laparoscopy | 3 | 2020 | 2035 | 0.110 |
Why?
|
| Lymphocyte Transfusion | 1 | 1994 | 232 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 438 | 0.100 |
Why?
|
| Poverty | 1 | 2024 | 2691 | 0.100 |
Why?
|
| Biological Products | 1 | 2022 | 915 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2011 | 3702 | 0.100 |
Why?
|
| Mimosine | 1 | 2011 | 8 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1549 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5666 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 614 | 0.100 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2011 | 23 | 0.100 |
Why?
|
| Ventricular Function, Left | 5 | 2011 | 3899 | 0.100 |
Why?
|
| Young Adult | 10 | 2024 | 59222 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2009 | 178 | 0.100 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2009 | 410 | 0.090 |
Why?
|
| Device Removal | 1 | 2016 | 629 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1668 | 0.090 |
Why?
|
| Transplantation Chimera | 1 | 1994 | 594 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2010 | 1885 | 0.090 |
Why?
|
| Cardiotonic Agents | 2 | 2011 | 540 | 0.090 |
Why?
|
| Colitis, Ulcerative | 1 | 2023 | 1920 | 0.090 |
Why?
|
| Sarcoma | 1 | 2022 | 1800 | 0.090 |
Why?
|
| Follow-Up Studies | 6 | 2024 | 39127 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13386 | 0.090 |
Why?
|
| Cyclopentanes | 1 | 2010 | 87 | 0.090 |
Why?
|
| Indiana | 1 | 2010 | 92 | 0.090 |
Why?
|
| Cholelithiasis | 1 | 1992 | 407 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1741 | 0.090 |
Why?
|
| Pericardiocentesis | 1 | 2010 | 78 | 0.090 |
Why?
|
| Ischemic Preconditioning | 1 | 2010 | 89 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2012 | 323 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2017 | 821 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 221 | 0.080 |
Why?
|
| Testosterone | 3 | 2010 | 2472 | 0.080 |
Why?
|
| LLC-PK1 Cells | 1 | 2009 | 125 | 0.080 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 136 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2019 | 1910 | 0.080 |
Why?
|
| Vasoconstriction | 2 | 2008 | 592 | 0.080 |
Why?
|
| Thymus Gland | 1 | 1994 | 1243 | 0.080 |
Why?
|
| Sex Characteristics | 5 | 2010 | 2640 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 13 | 2011 | 22128 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2010 | 233 | 0.080 |
Why?
|
| Adult | 16 | 2024 | 221120 | 0.080 |
Why?
|
| STAT Transcription Factors | 1 | 2009 | 189 | 0.080 |
Why?
|
| Arthritis | 1 | 1994 | 681 | 0.080 |
Why?
|
| Caspase 3 | 4 | 2011 | 730 | 0.080 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 522 | 0.070 |
Why?
|
| Janus Kinases | 1 | 2009 | 249 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 344 | 0.070 |
Why?
|
| Self Report | 1 | 2019 | 3727 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4190 | 0.070 |
Why?
|
| Cause of Death | 1 | 2018 | 3688 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2019 | 3923 | 0.070 |
Why?
|
| Estradiol | 3 | 2010 | 1937 | 0.070 |
Why?
|
| Nitriles | 2 | 2009 | 971 | 0.070 |
Why?
|
| Steroids | 2 | 2011 | 929 | 0.070 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2011 | 242 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2009 | 537 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 575 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 13632 | 0.070 |
Why?
|
| Reperfusion Injury | 2 | 2010 | 1026 | 0.070 |
Why?
|
| Platelet Transfusion | 1 | 2010 | 298 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 577 | 0.070 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2009 | 588 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 636 | 0.070 |
Why?
|
| Caspases | 1 | 2009 | 878 | 0.070 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2010 | 702 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 1994 | 2692 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2017 | 5969 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 620 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2000 | 4242 | 0.060 |
Why?
|
| Inflammation | 5 | 2011 | 10759 | 0.060 |
Why?
|
| Quinolines | 1 | 2010 | 764 | 0.060 |
Why?
|
| Mice, Knockout | 8 | 2011 | 14392 | 0.060 |
Why?
|
| Cryopreservation | 2 | 2021 | 728 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3805 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3808 | 0.060 |
Why?
|
| Disease Models, Animal | 7 | 2011 | 18222 | 0.060 |
Why?
|
| Ventricular Function, Right | 1 | 2008 | 618 | 0.060 |
Why?
|
| Time Factors | 4 | 2020 | 39957 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7965 | 0.060 |
Why?
|
| Sacrococcygeal Region | 1 | 2023 | 53 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 1963 | 0.060 |
Why?
|
| Mice | 17 | 2011 | 81330 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4487 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 2455 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2023 | 64681 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11733 | 0.050 |
Why?
|
| Antioxidants | 1 | 2011 | 1667 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1246 | 0.050 |
Why?
|
| Myocarditis | 1 | 2010 | 792 | 0.050 |
Why?
|
| Prognosis | 6 | 2023 | 29688 | 0.050 |
Why?
|
| Perfusion | 3 | 2011 | 1390 | 0.050 |
Why?
|
| Normetanephrine | 1 | 2021 | 25 | 0.050 |
Why?
|
| Ovariectomy | 2 | 2019 | 614 | 0.050 |
Why?
|
| Fetus | 1 | 2009 | 1864 | 0.050 |
Why?
|
| United States | 8 | 2024 | 72341 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1812 | 0.050 |
Why?
|
| Chromogranins | 1 | 2021 | 160 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2023 | 6819 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2010 | 4481 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5871 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 9979 | 0.040 |
Why?
|
| Recovery of Function | 4 | 2011 | 2981 | 0.040 |
Why?
|
| Groin | 1 | 2021 | 106 | 0.040 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2020 | 33 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2010 | 1513 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 1929 | 0.040 |
Why?
|
| Aged | 7 | 2023 | 169292 | 0.040 |
Why?
|
| Swine | 1 | 2009 | 5909 | 0.040 |
Why?
|
| Abdominal Wall | 1 | 2021 | 166 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2021 | 552 | 0.040 |
Why?
|
| Echocardiography | 1 | 2011 | 5006 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 2021 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 11476 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2011 | 5032 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2023 | 509 | 0.040 |
Why?
|
| Patient Selection | 1 | 2010 | 4246 | 0.040 |
Why?
|
| Colectomy | 1 | 2023 | 686 | 0.040 |
Why?
|
| Vincristine | 1 | 2020 | 1036 | 0.040 |
Why?
|
| Apoptosis | 2 | 2011 | 9478 | 0.040 |
Why?
|
| Cytokines | 2 | 2010 | 7386 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2018 | 24022 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2010 | 2278 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 220858 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1751 | 0.040 |
Why?
|
| Prevalence | 3 | 2021 | 15721 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2011 | 2665 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1996 | 509 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2008 | 1592 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3552 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4420 | 0.040 |
Why?
|
| Age Factors | 2 | 2011 | 18384 | 0.030 |
Why?
|
| Fundoplication | 1 | 2017 | 144 | 0.030 |
Why?
|
| Neural Crest | 1 | 2018 | 278 | 0.030 |
Why?
|
| Constipation | 1 | 2020 | 564 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 2381 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1757 | 0.030 |
Why?
|
| Phenols | 2 | 2009 | 517 | 0.030 |
Why?
|
| Macrophages | 1 | 2010 | 5755 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2010 | 3627 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2023 | 3590 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2017 | 249 | 0.030 |
Why?
|
| Siblings | 1 | 2019 | 824 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2023 | 54437 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2009 | 5921 | 0.030 |
Why?
|
| Hepatitis C Antibodies | 1 | 1995 | 147 | 0.030 |
Why?
|
| Togo | 1 | 1994 | 8 | 0.030 |
Why?
|
| Ovary | 1 | 2019 | 957 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 1996 | 5478 | 0.030 |
Why?
|
| Spondylitis | 1 | 1994 | 20 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2009 | 1240 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2021 | 1591 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2022 | 1201 | 0.030 |
Why?
|
| Arthritis, Gouty | 1 | 1994 | 28 | 0.030 |
Why?
|
| Oocytes | 1 | 2019 | 1165 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2023 | 41496 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2019 | 589 | 0.030 |
Why?
|
| Myocardial Contraction | 2 | 2009 | 1516 | 0.030 |
Why?
|
| Kidney | 2 | 2019 | 7033 | 0.030 |
Why?
|
| France | 1 | 1995 | 492 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4673 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 1480 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2018 | 938 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1633 | 0.030 |
Why?
|
| Recurrence | 2 | 2018 | 8457 | 0.030 |
Why?
|
| Nephrosis, Lipoid | 1 | 1993 | 45 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1994 | 752 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2011 | 1933 | 0.030 |
Why?
|
| Scoliosis | 1 | 2019 | 790 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 10756 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5114 | 0.020 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1992 | 81 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2011 | 166 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2011 | 221 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1994 | 1762 | 0.020 |
Why?
|
| Models, Biological | 4 | 2010 | 9458 | 0.020 |
Why?
|
| Lithotripsy | 1 | 1992 | 140 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2010 | 92 | 0.020 |
Why?
|
| Acute Disease | 2 | 2011 | 7226 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 3412 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2019 | 1294 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1994 | 1351 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2016 | 790 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2019 | 2241 | 0.020 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2009 | 58 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.020 |
Why?
|
| Proteinuria | 1 | 1993 | 605 | 0.020 |
Why?
|
| HMGB Proteins | 1 | 2009 | 45 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 12474 | 0.020 |
Why?
|
| Species Specificity | 1 | 1994 | 2406 | 0.020 |
Why?
|
| Biopsy | 2 | 2019 | 6781 | 0.020 |
Why?
|
| Castration | 1 | 2009 | 150 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2011 | 410 | 0.020 |
Why?
|
| Gliadin | 1 | 1989 | 80 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 1992 | 353 | 0.020 |
Why?
|
| Quality of Life | 2 | 2022 | 13367 | 0.020 |
Why?
|
| Flutamide | 1 | 2009 | 95 | 0.020 |
Why?
|
| Estrus | 1 | 2008 | 70 | 0.020 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1989 | 61 | 0.020 |
Why?
|
| Pyrazoles | 2 | 2009 | 2010 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 782 | 0.020 |
Why?
|
| Propionates | 1 | 2009 | 181 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 818 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2009 | 190 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2008 | 126 | 0.020 |
Why?
|
| Peritonitis | 1 | 2010 | 368 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2008 | 294 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 832 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2010 | 386 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 252 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 210 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 1553 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 1996 | 4822 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2000 | 10088 | 0.020 |
Why?
|
| Safety | 1 | 2012 | 1151 | 0.020 |
Why?
|
| Hepacivirus | 1 | 1995 | 1330 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1756 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3534 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1989 | 333 | 0.020 |
Why?
|
| Plant Proteins | 1 | 1989 | 374 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1994 | 1783 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2010 | 1250 | 0.020 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 1186 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 983 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 782 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 2393 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6417 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 463 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1695 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 2392 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 630 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 724 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1989 | 979 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3265 | 0.020 |
Why?
|
| Sex Factors | 2 | 2010 | 10553 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2008 | 655 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 11701 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20588 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3577 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 1559 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2008 | 1147 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1996 | 4373 | 0.010 |
Why?
|
| Extremities | 1 | 2009 | 867 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9278 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2010 | 1607 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5493 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1749 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2009 | 1611 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2010 | 1273 | 0.010 |
Why?
|
| Adipocytes | 1 | 2010 | 1190 | 0.010 |
Why?
|
| Models, Animal | 1 | 2009 | 2114 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1996 | 4574 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 1270 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2008 | 629 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2010 | 11512 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1404 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2475 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2916 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 29893 | 0.010 |
Why?
|
| Transfection | 1 | 2009 | 5748 | 0.010 |
Why?
|
| Regeneration | 1 | 2010 | 1505 | 0.010 |
Why?
|
| Antibodies | 1 | 1989 | 2415 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7865 | 0.010 |
Why?
|
| Radiography | 1 | 1992 | 6974 | 0.010 |
Why?
|
| Ischemia | 1 | 2009 | 1889 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2009 | 1408 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 4111 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2011 | 3111 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26072 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8519 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15841 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 15308 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3044 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1996 | 140 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2008 | 3813 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2008 | 5521 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36415 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8002 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 7851 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 11855 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1996 | 1867 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6200 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1992 | 58952 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1993 | 2359 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 14675 | 0.000 |
Why?
|